Intravenous infusion of clodronate can selectively deplete Kupffer cells without affecting ATMs, which is found to enhance insulin signaling and hepatic insulin sensitivity significantly in the case of an HFD; it could also reduce adipose tissue weight without affecting body weight, liver weight, or steatosis [104]. The gene discussed is INS; the disease is steatosis.